Comparison of two commercial molecular assays to a laboratory-developed molecular assay for diagnosis of Clostridium difficile infection

Tess Karre; Lynne Sloan; Robin Patel; Jayawant Mandrekar; Jon Rosenblatt

doi:10.1128/JCM.01028-10

Comparison of two commercial molecular assays to a laboratory-developed molecular assay for diagnosis of Clostridium difficile infection

Tess Karre, Lynne Sloan, Robin Patel, Jayawant Mandrekar, Jon Rosenblatt

Research output: Contribution to journal › Article › peer-review

17 Scopus citations

Abstract

We compared two commercial PCR assays, the Prodesse ProGastro CD assay and the BD GeneOhm Cdiff assay, with a laboratory-developed Clostridium difficile toxin PCR assay with previously established performance characteristics. Results of all methods were in agreement for 333 (96%) of 346 stool specimens. No significant difference in performance among the assays was found (P values, >0.05).

Original language	English (US)
Pages (from-to)	725-727
Number of pages	3
Journal	Journal of clinical microbiology
Volume	49
Issue number	2
DOIs	https://doi.org/10.1128/JCM.01028-10
State	Published - Feb 2011

ASJC Scopus subject areas

Microbiology (medical)

Access to Document

10.1128/JCM.01028-10

Cite this

@article{0f0b84d0606943d5b9b32bcd86590245,

title = "Comparison of two commercial molecular assays to a laboratory-developed molecular assay for diagnosis of Clostridium difficile infection",

abstract = "We compared two commercial PCR assays, the Prodesse ProGastro CD assay and the BD GeneOhm Cdiff assay, with a laboratory-developed Clostridium difficile toxin PCR assay with previously established performance characteristics. Results of all methods were in agreement for 333 (96%) of 346 stool specimens. No significant difference in performance among the assays was found (P values, >0.05).",

author = "Tess Karre and Lynne Sloan and Robin Patel and Jayawant Mandrekar and Jon Rosenblatt",

year = "2011",

month = feb,

doi = "10.1128/JCM.01028-10",

language = "English (US)",

volume = "49",

pages = "725--727",

journal = "Journal of clinical microbiology",

issn = "0095-1137",

publisher = "American Society for Microbiology",

number = "2",

}

TY - JOUR

T1 - Comparison of two commercial molecular assays to a laboratory-developed molecular assay for diagnosis of Clostridium difficile infection

AU - Karre, Tess

AU - Sloan, Lynne

AU - Patel, Robin

AU - Mandrekar, Jayawant

AU - Rosenblatt, Jon

PY - 2011/2

Y1 - 2011/2

N2 - We compared two commercial PCR assays, the Prodesse ProGastro CD assay and the BD GeneOhm Cdiff assay, with a laboratory-developed Clostridium difficile toxin PCR assay with previously established performance characteristics. Results of all methods were in agreement for 333 (96%) of 346 stool specimens. No significant difference in performance among the assays was found (P values, >0.05).

AB - We compared two commercial PCR assays, the Prodesse ProGastro CD assay and the BD GeneOhm Cdiff assay, with a laboratory-developed Clostridium difficile toxin PCR assay with previously established performance characteristics. Results of all methods were in agreement for 333 (96%) of 346 stool specimens. No significant difference in performance among the assays was found (P values, >0.05).

UR - http://www.scopus.com/inward/record.url?scp=79951481951&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951481951&partnerID=8YFLogxK

U2 - 10.1128/JCM.01028-10

DO - 10.1128/JCM.01028-10

M3 - Article

C2 - 21123537

AN - SCOPUS:79951481951

SN - 0095-1137

VL - 49

SP - 725

EP - 727

JO - Journal of clinical microbiology

JF - Journal of clinical microbiology

IS - 2

ER -

Comparison of two commercial molecular assays to a laboratory-developed molecular assay for diagnosis of Clostridium difficile infection

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this